Literature DB >> 28105268

Great Therapeutic Potential of Peptidylarginine Deiminase 4 (PAD4) Inhibitors: Treatment of Rheumatoid Arthritis, Epigenetic Tools, Regulation of Pluripotency in Stem Cells, and More.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2016        PMID： 28105268      PMCID： PMC5238471          DOI： 10.1021/acsmedchemlett.6b00515

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  Neutrophil extracellular traps - the dark side of neutrophils.

Authors:  Ole E Sørensen; Niels Borregaard
Journal:  J Clin Invest       Date:  2016-05-02       Impact factor: 14.808

2.  Pluripotency: citrullination unravels stem cells.

Authors:  Daniel J Slade; Venkataraman Subramanian; Paul R Thompson
Journal:  Nat Chem Biol       Date:  2014-05       Impact factor: 15.040

Review 3.  Peptidylarginine deiminase 4 and citrullination in health and disease.

Authors:  Consuelo Anzilotti; Federico Pratesi; Cristina Tommasi; Paola Migliorini
Journal:  Autoimmun Rev       Date:  2009-06-18       Impact factor: 9.754
  3 in total
  1 in total

Review 1.  The Expression of Non-Coding RNAs and Their Target Molecules in Rheumatoid Arthritis: A Molecular Basis for Rheumatoid Pathogenesis and Its Potential Clinical Applications.

Authors:  Chang-Youh Tsai; Song-Chou Hsieh; Chih-Wei Liu; Cheng-Hsun Lu; Hsien-Tzung Liao; Ming-Han Chen; Ko-Jen Li; Cheng-Han Wu; Cheih-Yu Shen; Yu-Min Kuo; Chia-Li Yu
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.